Concepedia

J. Paul Monk

JP

Statistics

Publications

29

Citations

2.3K

H-Index

18

Active since

2005

Affiliations

The Ohio State University(Current)

Johns Hopkins University

University of California, Davis

Memorial Sloan Kettering Cancer Center

The University of Texas Health Science Center at San Antonio

J. Paul Monk is an author at The Ohio State University specializing in medicine, urology, and oncology.

Top concepts

Publications per year

2005–2020

29

Publications

29

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

William Kevin Kelly, Susan Halabi, Michael A. Carducci et al. · Journal of Clinical Oncology · 2012 · 481 citations · Full text

Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer

Amir Goldkorn, Benjamin Ely, David I. Quinn et al. · Journal of Clinical Oncology · 2014 · 329 citations · Full text

Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)

Matthew R. Smith, Susan Halabi, Charles J. Ryan et al. · Journal of Clinical Oncology · 2014 · 246 citations · Full text

Assessment of Tumor Necrosis Factor Alpha Blockade As an Intervention to Improve Tolerability of Dose-Intensive Chemotherapy in Cancer Patients

J. Paul Monk, G Lewis Phillips, Ross Waite et al. · Journal of Clinical Oncology · 2006 · 178 citations · Full text

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

David I. Quinn, Catherine M. Tangen, Maha Hussain et al. · The Lancet Oncology · 2013 · 159 citations

, , +9

1–5 of 29